Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride (1:1), (3S,4R)-

CAS : 78246-49-8

Ref. IN-DA005NI7

Informations sur le produit

• Nom: Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, hydrochloride (1:1), (3S,4R)-
• Synonymes: [u'Aropax', u'BRL 29060', u'BRL-29060', u'BRL29060', u'FG 7051', u'FG-7051', u'FG7051', u'Paroxetine', u'Paroxetine Acetate', u'Paroxetine Hydrochloride Anhydrous', u'Paroxetine Hydrochloride Hemihydrate', u'Paroxetine Hydrochloride, Hemihydrate', u'Paroxetine Maleate', u'Paroxetine, cis-(+)-Isomer', u'Paroxetine, cis-(-)-Isomer', u'Paroxetine, trans-(+)-Isomer', u'Paxil', u'Seroxat', u'Paroxetine Hcl', u'78246-49-8', u'Paxil', u'Paroxat', u'Aropax 20', u'(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride', u'110429-35-1', u'BRL 29060 hydrochloride', u'UNII-3I3T11UD2S', u'Aropax', u'Paroxetine hydrochloride [USP]', u'BRL29060A', u'BRL 29060A', u'SDB 7175', u'3I3T11UD2S', u'Paroxetine hydrochloride hemihydrate (MW = 374.83)', u'HSDB 7175', u'S3005', u'C19H21ClFNO3', u'Paxil (TN)', u'Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S,4R)-', u'Paroxetine hydrochloride (USP)', u'CHEMBL1708', u'(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine hydrochloride', u'(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride', u'(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)-methyl)piperidine hydrochloride', u'(3S-TRANS)-3-[(1,3-BENZODIOXOL-5-YLOXY)METHYL]-4-(4-FLUOROPHENYL)PIPERIDINE HYDROCHLORIDE', u'Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S-trans)-', u'FG-7051', u'paroxatene', u'Paroxetine hydrochloride [USAN]', u'Paroxetine, HCl', u'AK-49032', u'paroxetine (Paxil)', u'MFCD03658863', u'AC1L1XYV', u'BRL29060 hydrochloride', u'C19H20FNO3.HCl', u'SCHEMBL33348', u'MLS002222322', u'PAROXETIN HYDROCHLORIDE', u'SPECTRUM1504085', u'CHEBI:7944', u'KS-00000JOT', u'DTXSID50228914', u'GELRVIPPMNMYGS-RVXRQPKJSA-N', u'BRL-29060A', u'HMS1922B11', u'Pharmakon1600-01504085', u'(-)-trans-paroxetine hydrochloride', u'(S)-3-(BENZO[1,3]DIOXOL-5-YLOXYMETHYL)-4-(4-FLUORO-PHENYL)-PIPERIDINE HYDROCHLORIDE', u'HY-B0492', u'Tox21_500095', u'ANW-49202', u'BG0380', u'CCG-39866', u'NSC758654', u'AKOS015849162', u'AKOS015907108', u'API0003757', u'CS-2611', u'H29P351', u'KS-5097', u'LP00095', u'NSC-758654', u'YF10047', u'(3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride', u'NCGC00093597-01', u'NCGC00260780-01', u'AN-15600', u'BR-49032', u'SMR001307264', u'AB0008509', u'AB1004558', u'AX8022605', u'LS-114251', u'TC-137947', u'TL8005348', u'EU-0100095', u'P1977', u'ST24025708', u'SW197457-4', u'D05374', u'J10285', u'Paroxetine or other medication - algorithm used', u'S-2491', u'110429-35-1(hemihydrate) 61869-08-7', u'SR-01000759305', u'SR-01000759305-6', u'Z1741971218', u'(-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-piperidine hydrochloride', u'(-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-piperidine hydrochloride', u'(-)-trans-4-(4-fluorophenyl)-3-(3,4-methylene dioxyphenoxymethyl)-piperidine hydrochloride', u'(3S,4R)-3-((BENZO[D][1,3]DIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE HCL']
• Marque: Indagoo

Propriétés chimiques

• Masse moléculaire: 365.8263
• Formule: C₁₉H₂₁ClFNO₃
• Degré de pureté: 99%
• Couleur/Forme: Solid
• InChI: InChI=1S/C19H20FNO3.ClH/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;/h1-6,9,14,17,21H,7-8,10-12H2;1H/t14-,17-;/m0./s1
• Code InChI: GELRVIPPMNMYGS-RVXRQPKJSA-N